Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 211

1.

Intravenous pamidronate in juvenile osteoporosis.

Shaw NJ, Boivin CM, Crabtree NJ.

Arch Dis Child. 2000 Aug;83(2):143-5.

2.

Intravenous bisphosphonate prevents symptomatic osteoporotic vertebral collapse in patients after liver transplantation.

Reeves HL, Francis RM, Manas DM, Hudson M, Day CP.

Liver Transpl Surg. 1998 Sep;4(5):404-9.

3.

Osteoporosis at presentation of childhood ALL: management with pamidronate.

Goldbloom EB, Cummings EA, Yhap M.

Pediatr Hematol Oncol. 2005 Oct-Nov;22(7):543-50.

PMID:
16166046
4.

Intravenous pamidronate as treatment for osteoporosis after heart transplantation: a prospective study.

Krieg MA, Seydoux C, Sandini L, Goy JJ, Berguer DG, Thiébaud D, Burckhardt P.

Osteoporos Int. 2001;12(2):112-6.

PMID:
11303710
5.

Intravenous pamidronate compared with oral alendronate for the treatment of postmenopausal osteoporosis.

Heijckmann AC, Juttmann JR, Wolffenbuttel BH.

Neth J Med. 2002 Sep;60(8):315-9.

6.

Better late than never? Experience with intravenous pamidronate treatment in patients with low bone mass or fractures following cardiac or liver transplantation.

Dodidou P, Bruckner T, Hosch S, Haass M, Klar E, Sauer P, Ziegler R, Leidig-Bruckner G.

Osteoporos Int. 2003 Jan;14(1):82-9.

PMID:
12577189
7.

The effect of intravenous pamidronate versus oral alendronate on bone mineral density in patients with osteoporosis.

Vis M, Bultink IE, Dijkmans BA, Lems WF.

Osteoporos Int. 2005 Nov;16(11):1432-5. Epub 2005 May 10.

PMID:
15883662
8.

Intravenous pamidronate in combination with calcium and vitamin D: highly effective in the treatment of low bone mineral density in inflammatory bowel disease.

Stokkers PC, Deley M, Van Der Spek M, Verberne HJ, Van Deventer SJ, Hommes DW.

Scand J Gastroenterol. 2006 Feb;41(2):200-4.

PMID:
16484125
9.

Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

Bayram F, Tanriverdi F, Kurtoğlu S, Atabek ME, Kula M, Kaynar L, Keleştimur F.

J Pediatr Endocrinol Metab. 2006 Mar;19(3):275-9.

PMID:
16607930
10.

Vertebral morphometry in children and adolescents with osteogenesis imperfecta: effect of intravenous pamidronate treatment.

Land C, Rauch F, Munns CF, Sahebjam S, Glorieux FH.

Bone. 2006 Oct;39(4):901-6. Epub 2006 May 26.

PMID:
16730480
11.

Bone densitometry in pediatric patients treated with pamidronate.

Grissom LE, Kecskemethy HH, Bachrach SJ, McKay C, Harcke HT.

Pediatr Radiol. 2005 May;35(5):511-7. Epub 2005 Jan 18.

PMID:
15655696
12.

How should clinicians manage osteoporosis in ankylosing spondylitis?

Bessant R, Keat A.

J Rheumatol. 2002 Jul;29(7):1511-9. Review.

PMID:
12136913
13.

[Bisphosphonate therapy for children and adolescents with primary and secondary osteoporotic diseases].

Semler O, Land C, Schönau E.

Orthopade. 2007 Feb;36(2):146-51. German.

PMID:
17252257
14.

The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.

Sbrocchi AM, Rauch F, Jacob P, McCormick A, McMillan HJ, Matzinger MA, Ward LM.

Osteoporos Int. 2012 Nov;23(11):2703-11.

PMID:
22297733
15.

Idiopathic juvenile osteoporosis.

Marhaug G.

Scand J Rheumatol. 1993;22(1):45-7.

PMID:
8434248
16.

High-dose bisphosphonate therapy in an urgent case of spontaneous multiple vertebral fractures in a 55 year old woman.

Muschitz C, Roschger P, Patsch J, Pollhammer I, Koller B, Klaushofer K, Resch H.

Wien Med Wochenschr. 2007;157(15-16):388-91.

PMID:
17922087
17.
18.

Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis.

Cauza E, Etemad M, Winkler F, Hanusch-Enserer U, Partsch G, Noske H, Dunky A.

J Clin Pharm Ther. 2004 Oct;29(5):431-6. Erratum in: J Clin Pharm Ther. 2005 Feb;30(1):96. Hanusch-Enserer, H [corrected to Hanusch-Enserer, U].

PMID:
15482386
19.

Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis.

Gandrud LM, Cheung JC, Daniels MW, Bachrach LK.

J Pediatr Endocrinol Metab. 2003 Jul-Aug;16(6):887-92.

PMID:
12948302
20.

Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.

Lucarelli S, Borrelli O, Paganelli M, Capocaccia P, Frediani T, Ferri F, Cucchiara S.

J Pediatr Gastroenterol Nutr. 2006 Oct;43(4):533-5. No abstract available.

PMID:
17033531
Items per page

Supplemental Content

Write to the Help Desk